Skip to main content
Signal8
Launch Terminal

Conexeu Sciences Inc. (CNXU)

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.

Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies

Industry: Biotechnology

Conexeu Sciences Inc. logo

Conexeu Sciences Inc.

NASDAQ:CNXUHealthcare
-6.06%$3.10
AH Close$3.31+6.77%vs close
Mkt Cap$95.58M
Float14.71M
O/S30.83M
Inst Own0.1%
SI1.4%
Dilution
Conexeu Sciences Inc. logoNASDAQ:CNXU$3.10-6.06%
Delisting Issues Timeline
Financials Summary

No financial data available.

Debt & Equity

No debt & equity data available.

Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in CNXU's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details

No balance sheet details available.

Income Statement

No income statement data available.

Balance Sheet

No balance sheet data available.

Cash Flow Statement

No cash flow data available.